You are here

obesity

Novo Nordisk pens $2B deal for triple G agonist tied to 15% weight loss at 12 weeks

Fierce Biotech

Mon, 03/24/25 - 11:20 am

United Laboratories

triple G agonists

Mira seeks to buy Skny for its preclinical obesity, smoking cessation asset

Fierce Biotech

Mon, 03/24/25 - 11:08 am

Mira Pharmaceuticals

Skny Pharmaceuticals

smoking cessation

Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy

Fierce Pharma

Mon, 03/24/25 - 11:05 am

NovoCare Pharmacy

Lilly, Novo expand DTC reach of obesity meds after compound win

Pharma Voice

Mon, 03/24/25 - 10:58 am

Gene therapy loses luster as investors eye quicker returns from weight-loss drugs

Yahoo/Reuters

Fri, 03/21/25 - 11:42 am

drug development

OPKO and Entera Bio partner on oral obesity treatment

Investing.com

Mon, 03/17/25 - 11:22 am

Altimmune to test obesity drug for alcohol use disorder and related health conditions

MSN/Reuters

Fri, 03/14/25 - 11:40 am

alcohol use disorder

MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup

BioPharma Dive

Thu, 03/13/25 - 11:25 pm

Parkinson's Disease

Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-life

Clinical Trials Arena

Wed, 03/12/25 - 11:18 pm

Harbour BioMed launches new obesity biotech on mission to preserve muscle mass

Fierce Biotech

Wed, 03/12/25 - 11:21 am

bispecific antibodies

Élancé Therapeutics

Roche builds in obesity with $5.3bn Zealand licensing deal

Pharmaphorum

Wed, 03/12/25 - 11:09 am

Viking secures 1b supply of obesity pill candidate with $150m prepayment deal

BioSpace

Tue, 03/11/25 - 11:32 am

Viking Therapeutics

Novo Nordisk's Ozempic successor disappointed Wall Street again

Yahoo Finance

Mon, 03/10/25 - 11:13 am

clinical trials

In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in

Fierce Pharma

Thu, 03/6/25 - 11:02 am

drug compounding

Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide

Fierce Biotech

Wed, 03/5/25 - 10:58 pm

clinical trials

AbbVie pays Gubra $350M to make late play for obesity space

Fierce Biotech

Mon, 03/3/25 - 11:02 am

India's Sun Pharma aims to launch its obesity drug in five years, managing director says

MSN/Reuters

Mon, 03/3/25 - 10:11 am

Where Will Eli Lilly Be in 5 Years?

Motley Fool

Sun, 03/2/25 - 09:41 pm

ulcerative colitis

As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access

BioSpace

Thu, 02/27/25 - 11:18 am

Kallyope links oral obesity combo to 3% weight loss, rejigs pipeline as migraine asset advances

Fierce Biotech

Thu, 02/27/25 - 11:09 am

clinical trials

Pages